NCT03989336 2024-07-15
A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer
Chinese PLA General Hospital
Phase 2 Completed
Chinese PLA General Hospital
On Target Laboratories, LLC
Huazhong University of Science and Technology